Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma
scientific article published on 16 May 2013
Author/s
author: Marc Remke, Dominik Sturm, Stefan Schulz, Martin Hasselblatt, Vijay Ramaswamy, Stefan Rutkowski, Marcel Kool, Andrey Korshunov, Michael D. Taylor, Nicolas Gerber, Michael Christoph Frühwald, Thomas Hielscher, Astrid Jeibmann
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.